11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases

11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular Diseases

Glucocorticoids (GCs) belong to the group of steroid hormones. Their representative in humans is cortisol. GCs are involved in most physiological processes of the body and play a significant role in important biological processes, including reproduction, growth, immune responses, metabolism, mainten...

Full description

Bibliographic Details
Main Authors:	Daria Kupczyk, Renata Studzińska, Renata Kołodziejska, Szymon Baumgart, Martyna Modrzejewska, Alina Woźniak
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Journal of Clinical Medicine
Subjects:	11β-hydroxysteroid dehydrogenase glucocorticoids metabolic syndrome cardiovascular diseases 11β-HSD1 selective inhibitors
Online Access:	https://www.mdpi.com/2077-0383/11/20/6190

Similar Items

Glucocorticosteroids – a new target in the treatment of metabolic syndrome
by: Szymon Baumgart, et al.
Published: (2024-04-01)

Synthesis of Novel 2-(Isopropylamino)thiazol-4(5<i>H</i>)-one Derivatives and Their Inhibitory Activity of 11β-HSD1 and 11β-HSD2 in Aspect of Carcinogenesis Prevention
by: Daria Kupczyk, et al.
Published: (2020-09-01)

Novel 2-(Adamantan-1-ylamino)Thiazol-4(5<i>H</i>)-One Derivatives and Their Inhibitory Activity towards 11β-HSD1—Synthesis, Molecular Docking and In Vitro Studies
by: Renata Studzińska, et al.
Published: (2021-08-01)

A Novel <i>N-Tert</i>-Butyl Derivatives of Pseudothiohydantoin as Potential Target in Anti-Cancer Therapy
by: Daria Kupczyk, et al.
Published: (2021-04-01)

Piper sarmentosum Effects on 11β-Hydroxysteroid Dehydrogenase Type 1 Enzyme in Serum and Bone in Rat Model of Glucocorticoid-Induced Osteoporosis
by: Siti Fadziyah Mohamad Asri, et al.
Published: (2016-11-01)

11β-hydroxysteroid dehydrogenase types 1 and 2 in postnatal development of rat testis: gene expression, localization and regulation by luteinizing hormone and androgens
by: Hong-Yu Zhou, et al.
Published: (2014-12-01)

Progress on the role of 11β-HSD1 in inflammation,development of hepatocellular carcinoma and immunity
by: LEI Xingyu, FENG Xuesong, CHAO Xu
Published: (2023-05-01)

The Effects of Piper Sarmentosum Water Extract on the Expression and Activity of 11β-Hydroxysteroid Dehydrogenase Type 1 in the Bones with Excessive Glucocorticoids
by: Elvy Suhana Mohd Ramli, et al.
Published: (2012-03-01)

11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases
by: Daria Kupczyk, et al.
Published: (2022-08-01)

11β-Hydroxysteroid dehydrogenase type 1 amplifies inflammation in LPS-induced THP-1 cells
by: Lingli Luo, et al.
Published: (2023-03-01)

Bisphenol A Analogues Inhibit Human and Rat 11β-Hydroxysteroid Dehydrogenase 1 Depending on Its Lipophilicity
by: Hong Wang, et al.
Published: (2023-06-01)

Synthesis of Novel 2-(Cyclopentylamino)thiazol-4(5<i>H</i>)-one Derivatives with Potential Anticancer, Antioxidant, and 11β-HSD Inhibitory Activities
by: Szymon Baumgart, et al.
Published: (2023-04-01)

Overexpression of 11β-hydroxysteroid dehydrogenase 1 in visceral adipose tissue and underexpression of endothelial nitric oxide synthase in the adrenal cortex of dogs with hyperadrenocorticism
by: Diego Daniel Miceli, et al.
Published: (2018-03-01)

Anti-inflammatory effects of levalbuterol-induced 11β-hydroxysteroid dehydrogenase type 1 activity in airway epithelial cells
by: Matthew J Randall, et al.
Published: (2015-01-01)

Pentacyclic Triterpenes from Cecropia telenitida Can Function as Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
by: Catalina Mosquera, et al.
Published: (2018-06-01)

11β-HSD1 participates in epileptogenesis and the associated cognitive impairment by inhibiting apoptosis in mice
by: Xueying Li, et al.
Published: (2022-09-01)

Evidence for transcript-specific epigenetic regulation of glucocorticoid-stimulated skeletal muscle 11β-hydroxysteroid dehydrogenase-1 activity in type 2 diabetes
by: Inder Warrick J, et al.
Published: (2012-12-01)

A Novel Selective 11β-HSD1 Inhibitor, (E)-4-(2-(6-(2,6-Dichloro-4-(Trifluoromethyl)Phenyl)-4-Methyl-1,1-Dioxido-1,2,6-Thiadiazinan-2-yl)Acetamido)Adamantan-1-Carboxamide (KR-67607), Prevents BAC-Induced Dry Eye Syndrome
by: Yoon-Ju Na, et al.
Published: (2020-05-01)

Idiopathic intracranial hypertension, hormones, and 11ß-hydroxysteroid dehydrogenases
by: Markey KA, et al.
Published: (2016-04-01)

Genotype, Mortality, Morbidity, and Outcomes of 3β-Hydroxysteroid Dehydrogenase Deficiency in Algeria
by: Asmahane Ladjouze, et al.
Published: (2022-06-01)

Grand Challenge in Adrenal Endocrinology: Is the Legacy of the Past a Challenge for the Future of Precision Medicine?
by: Iacopo Chiodini, et al.
Published: (2021-09-01)

Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 Contributes to Epidermal Permeability Barrier Dysfunction in Aged Skin
by: Beom Jun Kim, et al.
Published: (2021-05-01)

Methionine restriction effects on 11β-HSD1 activity and lipogenic/lipolytic balance in F344 rat adipose tissue
by: Carmen E. Perrone, et al.
Published: (2008-01-01)

Alteration in glucocorticoids secretion and metabolism in patients affected by cystic fibrosis
by: Rafał Podgórski, et al.
Published: (2022-12-01)

Can Resveratrol Influence the Activity of 11β-Hydroxysteroid Dehydrogenase Type 1? A Combined In Silico and In Vivo Study
by: Jurica Novak, et al.
Published: (2023-02-01)

Thiram, an inhibitor of 11ß-hydroxysteroid dehydrogenase type 2, enhances the inhibitory effects of hydrocortisone in the treatment of osteosarcoma through Wnt/β-catenin pathway
by: You Zhang, et al.
Published: (2023-03-01)

11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation
by: Chloe G Fenton, et al.
Published: (2022-06-01)

C11-hydroxy and C11-oxo C<sub>19</sub> and C<sub>21</sub> Steroids: Pre-Receptor Regulation and Interaction with Androgen and Progesterone Steroid Receptors
by: Rachelle Gent, et al.
Published: (2023-12-01)

Structural homology between 11 beta-hydroxysteroid dehydrogenase and Mycobacterium tuberculosis Inh-A enzyme: Dehydroepiandrosterone as a potential co-adjuvant treatment in diabetes-tuberculosis comorbidity
by: Israel Hernández-Bustamante, et al.
Published: (2023-01-01)

An inhibitor of 11-β hydroxysteroid dehydrogenase type 1 (PF915275) alleviates nonylphenol-induced hyperadrenalism and adiposity in rat and human cells
by: Ling-Ling Chang, et al.
Published: (2018-07-01)

Role of 11β-hydroxysteroid dehydrogenase 2 renal activity in potassium homeostasis in rats with chronic renal failure
by: N.L. Yeyati, et al.
Published: (2010-01-01)

Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 as Potential Drugs for Type 2 Diabetes Mellitus—A Systematic Review of Clinical and In Vivo Preclinical Studies
by: Cristiana Almeida, et al.
Published: (2021-01-01)

11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy
by: C. G. Fenton, et al.
Published: (2019-08-01)

Anti-inflammatory effect of a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor via the stimulation of heme oxygenase-1 in LPS-activated mice and J774.1 murine macrophages
by: Sung Bum Park, et al.
Published: (2016-08-01)

Interaction of a Novel Alternatively Spliced Variant of <i>HSD11B1L</i> with Parkin Enhances the Carcinogenesis Potential of Glioblastoma: Peiminine Interferes with This Interaction
by: Ru-Huei Fu, et al.
Published: (2023-03-01)

Endogenous glucocorticoids in inflammation: contributions of systemic and local responses
by: Rowan S. Hardy, et al.
Published: (2012-07-01)

Chronic food restriction up-regulates 11-β-hydroxysteroid dehydrogenase
by: Sledzinski Tomasz, et al.
Published: (2011-06-01)

Employing Molecular Docking Calculations for the Design of Alkyl (2-Alcoxy-2-Hydroxypropanoyl)-<i>L</i>-Tryptophanate Derivatives as Potential Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)
by: Diego Quiroga
Published: (2023-01-01)

Limonin ameliorates cisplatin-induced acute liver injury by inhibiting 11β-hydroxysteroid dehydrogenase type 1
by: Yadie Xiang, et al.
Published: (2023-12-01)

Development and structure–activity relationships of tanshinones as selective 11β-hydroxysteroid dehydrogenase 1 inhibitors
by: Xu Deng, et al.
Published: (2022-09-01)